Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-25T12:38:16.508Z Has data issue: false hasContentIssue false

Changes in the Output of 17-Ketosteroids After Shock Treatment, Pre-Frontal Leucotomy, and Other Procedures

Published online by Cambridge University Press:  08 February 2018

R. E. Hemphill
Affiliation:
Department of Endocrinology, Burden Neurological Institute, and Bristol Mental Hospital
L. D. MacLeod
Affiliation:
Department of Endocrinology, Burden Neurological Institute, and Bristol Mental Hospital
Max Reiss
Affiliation:
Department of Endocrinology, Burden Neurological Institute, and Bristol Mental Hospital

Extract

The estimation of the amount of neutral 17-ketosteroids excreted in the urine has attracted considerable attention, since the level of excretion (usually expressed as mgm./24 hours) can be fairly well correlated with the output of androgenic substances determined biologically (Callow et al., 1939a, b). What constitutes the normal range of daily output is still somewhat uncertain; 1.7 to 12.6 mgm. for females, 3.5 to 15 mgm. for males (Callow, 1939), 40 to 15 for normal women (Friedgood and Whidden, 1939), 4.3 to 21 mgm. (Chou and Wang, 1939), 3.5 to 14.6 mgm. for females, 9.4 to 20.4 for males (Patterson, McPhee, Greenwood, 1942) have been quoted. We have conducted investigations in a large number of cases of each sex in the last two years, and have come to regard 6 to 15 mgm. daily as the range for normal adults, females as a rule being lower in the scale than males; after middle age a somewhat reduced output is to be expected. It has been suggested (Patterson et al., 1942) that among normals higher values are related to larger body size, but we are unable to confirm this.

Type
Part II.—Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1942 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Barrera, S. E., and Kalinowsky, L. (1942), Arch. Neurol. and Psychiat., 47, 2, 367.Google Scholar
Callow, N. H., Callow, R. K., Emmens, C. W., and Stroud, S. W. (1939a), J. Endocrinol., 1, 76.Google Scholar
Callow, N. H., Callow, R. K., and Emmens, C. W. (1939b), Biochem. J., 32, 1312.CrossRefGoogle Scholar
Chou, C. Y., and Wang, C. W. (1939), Clin. J. Physiol., 14, 151.Google Scholar
Cobb, S. (1938), Arch. Int. Med., 62, 883.Google Scholar
Friedgood, H. B., and Whidden, H. L. (1939), New Engl. J. Med., 220, 736.Google Scholar
Patterson, J., McPhee, I. M., and Greenwood, A. W. (1942), Brit. Med. J., 1, 35.Google Scholar
Werner, S. C. (1941), J. Clin. Invest., 20, 21.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.